Little is known about the microvasculature of the myometrium and the changes that occur during pregnancy, where angioMonash University Department of Obstetrics & Gynaecology, genesis undoubtedly occurs as the myometrial smooth muscle Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, hypertrophies. Considerable research effort has been applied Australia to the study of angiogenesis associated with malignant tumours, 1 To whom correspondence should be addressed but there is little information about the role of angiogenesis Angiogenesis, defined as the growth of new vessels from in benign tumours including fibroids, smooth muscle tumours pre-existing vessels, involves microvascular rather than of the myometrium, which affect up to 50% of women during large vessel endothelial cells. Accordingly, microvascular their reproductive years (Vollenhoven, 1998). endothelial cell (MEC) proliferation assays are an appro-
1 To whom correspondence should be addressed but there is little information about the role of angiogenesis Angiogenesis, defined as the growth of new vessels from in benign tumours including fibroids, smooth muscle tumours pre-existing vessels, involves microvascular rather than of the myometrium, which affect up to 50% of women during large vessel endothelial cells. Accordingly, microvascular their reproductive years (Vollenhoven, 1998) . endothelial cell (MEC) proliferation assays are an appro-
The study of angiogenesis has been significantly advanced priate in-vitro model of angiogenesis. We have developed by the ability to culture endothelial cells (EC) in vitro. Initially a method for the isolation and long-term culture of large large vessel EC, such as those isolated from the human numbers of MEC from the human myometrium, tissue umbilical vein (HUVEC) were used for these studies (Jaffe readily available from hysterectomy specimens. Human et al., 1973) , but increasingly it has been recognized that myometrial MEC were positively selected from tissue dissomicrovascular endothelial cells (MEC) are a more appropriate ciated sequentially with collagenase and trypsin using Ulex model since angiogenesis involves MEC rather than large europeaus antigen-1 (UEA)-coated dynabeads. Cultured vessel EC (Hewett and Murray, 1993; Bicknell, 1996) . It is myometrial MEC displayed characteristic endothelial well known that EC are heterogeneous in phenotype, function, phenotype and function for up to 14 passages: cobblestone expression of surface molecules and responsiveness to growth morphology, formed capillary-like tubes on Matrigel, factors (Auerbach et al., 1985; McCarthy et al., 1991 ; Garlanda expressed CD31, Factor VIII-related antigen, bound UEA and Dejana, 1997) . Differences exist between large vessel and lectin, incorporated 1,1'-dioctadecyl-1,3,3,3Ј,3Ј-tetramicrovascular EC and the properties of arterial and venous methylindocarbocyanine perchlorate-labelled acetylated EC are also distinct (Hewett and Murray, 1993) . EC express low density lipoprotein, migrated and proliferated in organ-specific antigens and therefore differ between the various response to basic fibroblast growth factor (bFGF) and organs, but even within an organ, there is heterogeneity of EC vascular endothlelial growth factor (VEGF), but not from different vascular beds (Auerbach et al., 1985 ; Kumar epidermal growth factor. Optimal growth of human et al., 1987) .
myometrial MEC occurred in a simple medium comprising
In comparison to large vessel EC, MEC are difficult to M199, 5 ng/ml bFGF, 15% human serum, 5% fetal calf isolate and culture. MEC only comprise 1-5% of the cells in serum (FCS) and heparin. Human serum was essential for a given tissue, they grow slowly in culture and are contactgrowth, although there was a synergistic effect when FCS inhibited. As a result, MEC cultures are often overgrown was included. Almost identical dose-response curves were by faster growing, non-contact-inhibited fibroblasts, smooth obtained for bFGF-and VEGF-induced myometrial MEC muscle cells and pericytes, usually limiting passage number proliferation in early and late passage cells. Therefore to five or six (Hewett and Murray, 1993; Bicknell, 1996) . A myometrial MEC are a good model for in-vitro studies of significant improvement in the culture of MEC came with uterine angiogenesis, since they have a stable phenotype the use of superparamagnetic bead technology (Dynabeads). and proliferative responsiveness to VEGF and bFGF for Initially Dynabeads were coupled with the lectin Ulex up to 14 passages.
europeaus agglutinin-1 (UEA-1) which binds to α-fucosyl Key words: angiogenesis/endothelial cell/microvascular/myoresidues on an EC-specific glycoprotein (Jackson et al., 1990) . metrium This approach has been extended by using antibodies to specific EC markers such as CD31 (Hewett and Murray, 1993) , tumour necrosis factor (TNF)-α-induced E-selectin (Richard et al., 1998) and CD34 (Iruela-Arispe et al., 1999) . These Introduction techniques have significantly increased the yields and purity of MEC obtained from a variety of tissues after initial enzyme The microvascular endothelium has a critical role in angiogenesis, the process by which new blood vessels develop from dissociation. Microvascular EC have previously been isolated from a pre-existing vessels. In the adult, angiogenesis rarely occurs under normal circumstances, except in the female reproductive number of human tissues including neonatal foreskin, brain, omentum, synovium, retina, endometrium and decidual tissue tract during the menstrual cycle and pregnancy (Risau, 1997) .
deoxyribonuclease type I for 10 min at 37°C to digest the remaining (Jackson et al., 1990; Su and Gilles, 1992; Grimwood et al., microvessel fragments and obtain single cell suspensions. The cells 1995; Chung-Welch et al., 1997; Richard et al., 1998; Iruela- were washed and resuspended at 2.5ϫ10 7 /ml in HEPES-buffered Arispe et al.,1999) . Few have attempted to isolate and culture M199 medium containing 1% FCS. Cell viability was measured using MEC from muscular organs, although there are reports on the Trypan Blue dye exclusion and was~70 and 60% after collagenase isolation of MEC from the human myocardium (Nishida et al., and trypsin treatment respectively. 1993; McDouall et al., 1996) . There have been no detailed Dynal M-450 magnetic beads (Dynal, Oslo, Norway) were coated reports on the isolation and culture of MEC from the human with lectin by incubating 2ϫ10 7 beads with UEA-1 (1 mg/ml in 0.1 myometrium, a highly vascular tissue that is readily available mol/l borate buffer, pH 8.5) (Sigma) in a 200 µl volume for 24 h at from hysterectomy specimens. In the present study we report 4°C, according to the manufacturer's instructions. The beads were on the isolation and long-term culture of MEC from the human collected using a magnetic particle concentrator (MPC; Dynal) and washed three times in PBS/0.1% BSA (one an overnight wash) and myometrium to serve as a model of MEC derived from sex resuspended at 2ϫ10 8 /ml in PBS/BSA. steroid hormone-responsive tissue and for our studies of of angiogenesis.
Microvascular endothelial cell culture
The purified MEC were resuspended in a standard culture medium
Materials and methods
comprising M199 with Earle's salts containing heat-inactivated 15% Human tissues pooled male human serum (HS) (obtained from Red Cross Blood Service and male staff volunteers) and 5% FCS (CSL, Melbourne, Human myometrial tissue was obtained from normal ovulating women Australia), 2 mmol/l glutamine (Gibco BRL), 5 ng/ml bFGF (Gibco undergoing hysterectomy (aged 20-40 years) without underlying BRL), 0.1 mg/ml heparin (Gibco BRL), and antibiotic/antimycotic, uterine pathology, usually for prolapse. In some cases, myometrium seeded into culture flasks at 8-10ϫ10 4 cells/cm 2 coated with 10 µg/ was obtained from women undergoing hysterectomy for fibroids. ml fibronectin (Gibco BRL) and incubated in a humidified atmosphere Tissues included in this study were from women who had not taken at 37°C in 5% CO 2 in air. To minimize culture variability the same exogenous hormones in the previous 3 months. Informed consent batch of human serum was used for each set of experiments. was obtained from each patient and ethical approval from the Monash For some isolations 0.5 µg/ml hydrocortisone (Sigma), 330 µmol/l Medical Centre Human Research and Ethics Committee.
3-isobutyl-1-methyl xanthine (IBMX; Sigma), 2 mmol/l MgSO 4 A small portion of each piece of tissue was fixed for 4 h in 10%
(complex culture medium) were also included in the culture medium. phosphate-buffered formalin (pH 7.4) for routine paraffin embedding.
Medium was changed every 2-3 days and at 70-80% confluence, Sections (5 µm) were used for immunohistochemical analysis. The MEC were trypsinized (0.025% trypsin: 0.27 mmol/l EDTA) and remaining tissue (2-7 g) was collected in HEPES-buffered M199 repurified with UEA-1-coated Dynabeads and subcultured at a split culture medium (Gibco BRL, Gaithersburg, MD, USA) containing ratio of 1:3 on 0.2% gelatin-coated (Sigma) T175 Falcon tissue 10% FCS and antibiotic-antimycotic solution (Gibco BRL) with final culture flasks (Beckton Dickinson, Bedford, MA, USA). On some concentrations of penicillin 1000 U/ml, streptomycin 1000 U/ml and occasions it was necessary to remove contaminating smooth muscle fungizone 2.5 µg/ml. The tissue was stored overnight at 4°C and then cells with a further Dynabead purification at a later passage. For processed.
freezing, MEC (5ϫ10 6 to 2ϫ10 7 ) were resuspended in 20% FCS/ Microvascular endothelial cell isolation and purification 10% DMSO (Sigma)/70% culture medium and slowly cooled to -80°C and then stored in liquid N 2 . Thawed cells were gently washed The endometrial layer of the uterine tissue was identified, removed in culture medium and seeded at 1.5ϫ10 4 /cm 2 on fibronectinand discarded together with the first 1 mm of myometrial tissue and coated flasks. the outer third of the myometrium, thus removing any of the serosa and mesothelial layer. The inner 2/3 of the myometrium was then Immunohistochemistry finely chopped for enzyme dissociation, since the inner layers of myometrium show greater responses to sex steroid hormones com-MEC were grown on 13 mm gelatin-coated Thermanox coverslips (Nunc, Roskilde, Denmark) and when confluent were rinsed in PBS pared to the outer third (Noe et al., 1999) . Chopped tissue was digested with 2 mg/ml collagenase type 2 (Worthington, Biochemical and fixed in cold acetone for 2 min. Standard immunohistochemistry protocols (Abberton et al., 1999; Goodger (MacPherson) and Rogers, Corporation, Freehold, NJ, USA) and 14.5 µg/ml deoxyribonuclease type I (Boehringer Mannheim GmbH, Mannheim, Germany) in Ca 2ϩ -1994; Gargett et al., 1999) were used after first blocking sections with 0.03% H 2 O 2 for 10 min at room temperature (RT) and protein and Mg 2ϩ -free phosphate buffered saline (PBS, pH 7.4) containing 0.1% bovine serum albumin (BSA) (Sigma Chemical Co., St Louis, blocking reagent (PBA) (Lipshaw Immunon, Pittsburgh, PA, USA) for 10 min at RT. The primary antibodies were then incubated for MO, USA) for 2 h at 37°C in a shaking water bath. The cloudy supernatant containing single cells was sequentially removed at 30 1 h at 37°C, followed by biotinylated rabbit anti-mouse or goat antirabbit secondary antibodies (1/100) for 30 min at RT, streptavidinmin intervals during the dissociation procedure and placed into HEPES-buffered M199 medium containing 50% FCS and stored at HRP conjugate (Zymed, San Francisco, CA, USA) for 30 min at RT and AEC chromogen (Zymed) for 10 min. The following primary 4°C until all the tissue was dissociated. Fresh enzyme solution was added back to the digesting tissue. The cell suspensions were collected, antibodies were used: rabbit anti-human Factor VIII-related antigen at 20 µg/ml (Zymed), mouse anti-human CD31, 8.2 µg/ml (Zymed), diluted in M199 medium and filtered through 100 µm stainless steel mesh (Sigma), washed several times and incubated with trypsin:EDTA mouse anti-human CD34, 0.1 µg/ml (QBEND/10 clone; Serotec, Oxford, UK), mouse anti-human α smooth muscle actin, 0.18 µg/ml (0.05% trypsin: 0.53 mmol/l EDTA, Gibco BRL) and 24 µg/ml (Dako Ltd, High Wycombe, UK), mouse anti-human cytokeratin, 2 antibody (R&D Systems) respectively for 48 h at 37°C in 5%CO/air and the same field of view was rephotographed. µg/ml (Clone MNF116; Dako). Ulex europeaus A-1 binding antigen was detected on MEC grown on coverslips and in tissue sections of MEC tube forming assay myometrium using 20 µg/ml biotinylated UEA-1 lectin (Sigma) for 30 min at room temperature, followed by streptavidin-HRP conjugate Wells of a 24-well plate were coated with 400 µl undiluted Matrigel and AEC. For negative controls, primary antibodies were substituted (growth factor reduced; Collaborative Research, Cat. no. 40230) and with an isotype matched IgG at the equivalent concentration of allowed to polymerize at 37°C for 1 h. Early (P3) and late (P13) primary antibody. Immunohistochemical procedures were performed MEC in simplifed M199 medium were seeded onto the Matrigelon six separate MEC cultures at various passages. coated wells at 6ϫ10 4 /well and incubated 24 h at 37°C in 5% CO 2 / air, examined for tube formation under an inverted phase contrast microscope and photographed. Uptake of DiI-Ac-LDL The presence of scavenger receptors for acetylated low density Statistical analysis lipoprotein (ac-LDL) on MEC was detected using 1,1'-dioctadecylData were analysed by Student's t-test using Excel software. P Ͻ 1,3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate acetylated LDL 0.05 was considered significant. (DiI-Ac-LDL, Molecular Probes, Eugene, OR, USA). Confluent MEC cultured in 24-well plates on 0.2% gelatin were incubated with 15 µg/ml DiI-Ac-LDL in culture medium for 4 h at 37°C in 5% CO 2 / Results air according to a published method (Voyta et al., 1984) . LDL uptake Isolation and culture of human myometrial microvascular was examined using a Zeiss Axiovert 100 epifluorescence microscope, endothelial cells using an optical bandpass filter set with an excitation of 545 nm and emission of 590 nm.
Human myometrium is a highly vascularized tissue as demonstrated by UEA binding to tissue sections ( Figure 1A ). We
Endothelial cell proliferation assay
have adapted the UEA-1-coated Dynabead selection method
The CellTitre 96 MTS tetrazolium-based bioassay (Promega, Madison, of (Jackson et al., 1990) the perinuclear region and at sites of cell-cell contact ( Figure  1F ) and took up DiI-Ac-LDL via the scavenger LDL receptor MEC migration assay ( Figure 2D) . A characteristic feature of EC, which distinguishes Early-(P3) and late-(P13) passage MEC were cultured in standard them from mesothelial cells (Chung-Welch et al., 1989) , is M199 culture medium in 0.2% gelatin-coated wells of a 24-well plate their ability to differentiate into capillary-like tubes when until confluent. The medium was changed to basal medium, the MEC cultured on the basement membrane matrix, Matrigel. immunostain with cytokeratin antibodies (results not shown) 40% HS stimulated significant MEC proliferation (P Ͻ 0.03) ( Figure 3A ). While myometrial MEC survived in FCS conor express the smooth muscle cell marker, α-smooth muscle actin, as seen by the lack of staining of the MEC in the taining medium, neither bFGF ( Figure 3A ) nor VEGF (results not shown) induced significant MEC proliferation, even at background of Figure 1G .
high FCS concentrations. However, both bFGF ( Figure 3B ) Growth requirements and characteristics of human myometrand VEGF (results not shown) stimulated even greater levels ial MEC of MEC proliferation when combinations of HS and FCS were present in the medium ( Figure 3B ). The optimal combination Figure 3 shows that myometrial MEC had an absolute requirement for human serum for growth stimulated by either bFGF was 15% HS and 5% FCS ( Figure 3B ). Agents that increase intracellular levels of adenosine 3Ј,5Ј-( Figure 3A ) or VEGF (results not shown), and that this effect was dose-dependent. Even in the absence of growth factor, cyclic monophosphate (cAMP) are commonly used in the medium for culture of MEC to stimulate their growth (Karasek, and for bFGF, 0.6 and 0.9 ng/ml. The difference in absorbance between maximal and minimal response measured at day 6 1989). The effect of a cAMP phosphodiesterase inhibitor, was significantly greater for high passage MEC compared to 3-isobutyl-1-methyl xanthine (IBMX 330 µmol/l) and a memlow passage MEC for bFGF: 0.50 Ϯ 0.07 (n ϭ 3) versus 0.82 brane permeant cAMP analogue, dibutyryl cAMP (N-6,2Ј-O-(n ϭ 2) respectively (P ϭ 0.044); but not for VEGF: 0.51 Ϯ dibutyryl adenosine 3Ј,5Ј-cyclic monophosphate, 50 µmol/l, 0.09 (n ϭ 3) versus 0.70 (n ϭ 2) respectively (P ϭ 0.33). Sigma), was examined on bFGF-stimulated MEC proliferation.
These results indicate that late passage MEC proliferate at a Figure 4 shows that bFGF stimulated significantly greater greater rate in response to bFGF compared to early passage proliferation of myometrial MEC over 10 days in the absence MEC. of either IBMX or dibutyryl cAMP (P Ͻ 0.05). After 5 days greater growth was observed in the absence of dibutyryl cAMP Migration responses of myometrial MEC (P Ͻ 0.02) but not IBMX (Figure 4 ). Hydrocortisone had no An integral part of the angiogenic process is the ability of significant effect on bFGF-induced myometrial MEC prolifera-MEC to migrate toward an angiogenic stimulus, such as a tion in the presence or absence of either IBMX or dibuytryl source of VEGF (Goodman et al., 1985; Ferrara and DaviscAMP (results not shown) . Smyth, 1997) . The migratory capacity of MEC to certain The responsiveness of human myometrial MEC to a range growth factors can be assessed in vitro using Boyden chamber of growth factors, known to induce proliferation of EC derived or monolayer wound assays. The migration of early and late from other tissues, was determined by stimulating MEC with passage myometrial MEC in response to bFGF and VEGF maximal concentrations of growth factors for 6 days. Figure  was examined using the monolayer wound assay (Goodman 5 shows that ECGS and bFGF were equally effective and et al., 1985) in the presence and absence of neutralizing bFGF produced maximal stimulation of MEC proliferation, followed and VEGF antibodies. After a 48 h incubation in basal medium by the two VEGF isoforms, VEGF 121 and VEGF 165 . ECGF in the presence of bFGF or VEGF, both high and low passage and EGF were weakly mitogenic for myometrial MEC. Both MEC migrated into the denuded area to a comparable extent, VEGF 165 and bFGF stimulated myometrial MEC proliferation and this migration was completely inhibited by the respective in a dose-dependent manner over the concentration range 0.01-neutralizing antibodies to each growth factor ( Figure 7 , Table I ). 20 ng/ml (Figure 6 ). The dose-response curves obtained for high and low passage MEC were very similar for bFGF and Discussion VEGF when reported as the mean percentage of maximal responses (Figure 6 ). The approximate EC 50 for VEGF was Although MEC have been isolated and cultured from a variety of tissues, this is the first detailed report of the characterization 1.5 and 1.6 ng/ml for early and late passage MEC respectively Figure 5 . Growth response curves of myometrial microvascular endothelial cells stimulated with maximal concentrations of growth factors. Quiescent P5 MEC were incubated in M199 culture medium containing 20% human serum in the absence (d) or presence of (j) 120 mg/ml endothelial cell growth supplement ECGS, (u) 20 mg/ml endothelial cell growth factor (ECGF), (e) 10 ng/ml bFGF, two isoforms of vascular endothelial growth factor (VEGF), VEGF 121 (m), VEGF 165 (n), each 10 ng/ml and (s) 50 ng/ml epidermal growth factor and absorbance measured as indicated. Results shown are means Ϯ SEM from a single experiment, representative of three.
of MEC isolated and cultured from human myometrium. Oestrogen receptor expression in human myometrial MEC has been described in one study, but the details of their culture method were scanty (Tschugguel et al., 1997) . Myometrial eously formed capillary-like tubes on basement membrane matrix, expressed classical endothelial cell markers, CD31, Factor VIIIra, bound UEA-1 lectin and took up DiI-ac-LDL. Futhermore, myometrial MEC migrated and proliferated in response to VEGF and bFGF. Thus myometrial MEC showed typical morphology, phenotype and function of endothelial cells for up to 14 passages.
Certain procedures were important for the successful isolation of MEC, since the presence of too many contaminating smooth muscle cells in the initial stages would result in overgrowth of the slower growing MEC. The success of UEA-1-coated Dynabead purification of the dissociated myometrial tissue relied on the two-step digestion procedure of (Grimwood et al., 1995) , where collagenase treatment was followed by a short trypsinization to produce a single cell suspension. Excess- binding with fucose (Jackson et al., 1990) , and heavily bead- (Newman, 1997) , and also has a role in angiogenesis two experiments for high passage MEC, which varied less than (DeLisser et al., 1997) . Presumably ligation of CD31 with 10% and 18% for VEGF and bFGF respectively. bead-attached antibodies on the MEC inhibited the cell-cell interactions necessary to establish successful monolayer cultures. remained through all passages until senescence was reached. In contrast, Tschugguel et al. (1997) cultured human myometrial
The migration of MEC into a denuded area of the culture well following MEC in 20% FCS, but provided no further details. We believe wounding of the monolayer was evaluated semi-quantitatively, represented by: ϩ/-, very low; ϩ, low; ϩϩ, medium; ϩϩϩ, high coverage of the that the use of HS is one of the contributing factors in our denuded area.
ability to culture myometrial MEC for a greater number of passages than most other human MEC. Although myometrial MEC proliferated poorly in FCS, when both FCS and HS were coated cells were unable to attach to fibronectin-coated flasks. However, we found that MEC purified by UEA-1-coated used in combination, greater rates of growth were always observed, suggesting that the action of essential component(s) dynabeads attached more readily and produced more reliable cultures than when CD31-coated dynabeads were used present in HS were enhanced by an unknown constituent of FCS, which alone was ineffectual. Similarly, Abbott et al. (K.Bucak and C.E.Gargett, unpublished data). CD31 or platelet (1996) found that a mix of FCS and HS gave optimal growth and Bischoff, 1998), although decidual MEC are a notable exception (Grimwood et al., 1995) . for human synovial MEC. MEC cultured from a number of In summary, we have isolated and cultured MEC from human tissues vary in their serum requirements, highlighting human myometrium and characterized their phenotype and the heterogeneity of MEC from vascular beds of different growth characteristics. We have described a simplified culture tissues. For example, MEC derived from decidual tissue medium that is suitable for the study of proliferative responses, (Gallery et al., 1991; Grimwood et al., 1995) , heart (McDouall which make myometrial MEC a good model for in-vitro et al., 1996) , synovium (Abbott et al., 1996) and the pseudoinangiogenesis assays. Myometrial MEC also have a stable tima of vascular stents (Sanyal and Mirshahi, 1998) all failed phenotype and proliferative responsiveness to VEGF and bFGF to proliferate in FCS, but proliferated well in HS, while MEC for up to at least 13 passages. Large numbers of MEC are cultured from neonatal foreskins (Jackson et al., 1990; Kräling obtainable from a single specimen of myometrial tissue, which and Bischoff, 1998; Richard et al., 1998) , omentum (Chungis readily available from hysterectomy specimens. Myometrial Welch et al., 1997) and the gastric or intestinal mucosa MEC should prove a useful model of MEC from sex steroid- (Haraldson et al., 1995; Hull et al., 1996) proliferated well in responsive tissue showing similar characteristics to decidual FCS. The ability of these human MEC to proliferate in the MEC, only differing in their response to bFGF. We have also presence of FCS is not dependent on the molecular selection used the protocol outlined in this report to isolate and culture of endothelial cell subtypes (i.e. capillary versus venule), since MEC from human endometrium where the yield is much dermal MEC isolated using UEA-1, CD31 or inducible Ehigher, but the amount of tissue available for culture much selectin markers all grow in FCS. Rather, it appears that the less (K.Bucak and C.E.Gargett, unpublished observations). proliferative responses of some human MEC are dependent Furthermore, we have successfully isolated and cultured MEC on a component present in HS, which is not found in FCS.
from fibroids, benign smooth muscle tumours of the myomeOne of the advantages of using myometrial MEC for trium, for our studies examining the role of angiogenesis in angiogenesis assays is their ability to proliferate in a relatively the development of these tumours (M.Zaitseva and C.E.Gargett, simple culture medium compared to many other human MEC.
unpublished data). Fibroid and myometrial MEC should also In particular, agents which raise the intracellular concentration prove very useful in the study of angiogenesis in the pregnant of cAMP were not only unnecessary but actually had an uterus and in disorders of the myometrium such as fibroids. inhibitory effect on myometrial MEC growth. We believe this to be a major advantage, since cAMP is a second messenger signalling molecule which functions as a downstream regulator Acknowledgements for many receptor-mediated events in EC. The presence of cAMP promoters in growth medium for MEC therefore comWe with to thank Debbie Plunkett and Fiona Lederman for their technical assistance with the immunohistochemistry, the gynaecoloplicates any investigation examining receptor-mediated func- (Krupinski, 1991) . We also found Foundation (P.A.W.R.).
it unnecessary to include corticosteroids in the culture medium of myometrial MEC, since hydrocortisone had no beneficial or detrimental effect on growth. Similarly, Kräling and Bischoff References (1998) bFGF-stimulated proliferation of human dermal MEC.
Reprod., 14, 1072-1079.
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